Home › Celgene Global Health, DNDi expand partnership to identify new drug candidates for NTDs
 

Keywords :   


Celgene Global Health, DNDi expand partnership to identify new drug candidates for NTDs

2014-09-24 15:55:26| Biotech - Topix.net

Celgene Global Health , a division of Celgene Corporation , and the Drugs for Neglected Diseases initiative strengthen their collaboration with a four-year Research Collaboration Agreement to identify and optimize new drug candidates for the treatment of neglected tropical diseases . Celgene will provide DNDi with new data and resources to accelerate clinical development of new treatments for patients with NTDs.

Tags: health global expand drug

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
23.09AWA releases Glue-Applied Label Market Report 2024
23.09Hurricane John Graphics
23.09Hurricane John Forecast Discussion Number 5
23.09Hurricane John Wind Speed Probabilities Number 5
23.09Eastern North Pacific Tropical Weather Outlook
23.09Hurricane John Forecast Advisory Number 5
23.09Hurricane John Public Advisory Number 5
23.09Potential Tropical Cyclone Nine Public Advisory Number 1A
More »